Clinical Trial Update: A Study of Sacituzumab Govitecan in People With Mesothelioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Sacituzumab Govitecan for mesothelioma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma
• Pleural Mesothelioma

Drugs mentioned

• Sacituzumab Govitecan (sacituzumab govitecan)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Mesothelioma, Mesotheliomas Pleural | Phase 2 | Status: RECRUITING